Accessing key EMA information on human medicines

A guide, released today by the European Medicines Agency (EMA), describes information the Agency publishes on centrally and non-centrally authorised medicines for human use.

Providing an overview of the range of documents produced by EMA during the life span of a medicine, the guide covers early development, through initial evaluation, adoption of positive or negative opinions, post-authorisation changes and safety reviews.

Click on this link for more information.

#LegislationRegulatoryAffairs #RegulatoryAffairsHuman #Pharmanews